InsidersTradesSigma
Apyx Medical Corp: directors' dealings · United States · SEC (Form 4)
SEC:apyx-medical-corp-d67db3US·SEC (Form 4)Mcap 166M€Healthcare
Explore the full directors' dealings record of Apyx Medical Corp, a publicly traded company based in United States. Shares are listed on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Apyx Medical Corp has published 3 public disclosures. Market capitalisation: €166m. The latest transaction was disclosed on 23 May 2022 — Levée d'options. Among the most active insiders: Waldman Lawrence. The full history is openly available.
3
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
3.96 €
Analyst consensus
4 analystsStrong buy
6.00 €Target 6.50 €(+64%)8.00 €
Income statement
Revenue52.8 M€
Gross profit33.0 M€63% margin
Net income−11.2 M€-16.4% margin
Valuation
PER (forward)-15.1x
P/Book13.0x
Balance sheet & cash
Market cap166.0 M€
Total debt39.3 M€
Free Cash Flow−9.1 M€
Debt / Equity302%
Profitability & ownership
ROE-76.5%
ROA-4.4%
% insiders13.3%
% institutions49.6%
Last declaration on 23 May 2022
Declarations3 total
Executives◇Options26SEC
€21,0988,000 shares@ €2.63730.013% mcap100.0% of flow
Common Stock
SEC:0000719135-22-000037:0·
Executives◇Options25SEC
€15,9246,000 shares@ €2.6540.0096% mcap100.0% of flow
Common Stock
SEC:0000719135-22-000035:0·
Executives◇Options29SEC
€76,66317,000 shares@ €4.50960.046% mcap100.0% of flow
Common Stock
SEC:0000719135-22-000024:0·
3 of 3 declarations